Method for detecting environmental estrogen based on fluorescence polarization immunoassay technology

Through the detection method based on fluorescence polarization immunoassay technology, the reaction between fluorescent probes and estrogen receptors is used to solve the problem of low environmental estrogen detection efficiency in the marine environment, and efficient and rapid monitoring of estrogen in the marine environment is achieved. , with high sensitivity and selectivity.

CN119023637APending Publication Date: 2024-11-26GUANGDONG UNIV OF TECH
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202411153722.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-21
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

The existing detection methods have low efficiency in detecting environmental estrogens in marine environments, insufficient sensitivity and specificity, and cannot effectively monitor and identify unidentified environmental estrogens, especially in marine environments where the concentration trace amount and matrix complexity are found. Down.

Method used

Using detection methods based on fluorescence polarization immunoassay technology, we designed the reaction of the synthetic fluorescent probe F-E2 and the human estrogen receptor ERα-LBD, combined with competition and binding experiments, measured the polarized light intensity value, and mapped the 17β-estradiol standard Inhibition curve to determine the estrogen residue of the sample.

Benefits of technology

It realizes rapid, efficient and simultaneous monitoring of a wide range of estrogen substances in the marine environment, with high selectivity and sensitivity, detection limit is 8.065nM, and linear range is 25.218~663.035nM, which is suitable for large-scale sample detection and simplifies the operation process. And improve detection speed.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119023637A_ABST
    Figure CN119023637A_ABST
Patent Text Reader

Abstract

The invention provides a method for detecting environmental estrogen based on a fluorescence polarization immunoassay technology. The method comprises the following steps: S1, preparing a fluorescent probe F-E2; s2, acquiring the concentration of a fluorescent probe F-E2; s3, obtaining the concentration of a human estrogen receptor ER alpha-LBD; s4, incubating a reaction mixture of the fluorescent probe F-E2 and the receptor ER alpha-LBD at room temperature; s5, adding 17 beta-estradiol into the reaction mixture, and measuring a corresponding mP value; s6, drawing a corresponding 17 beta-estradiol standard inhibition curve according to the mP value; and S7, detecting an actual sample according to the method in the step S5, comparing the detected polarized light intensity value with the standard inhibition curve of 17 beta-estradiol, and determining the estrogen residual quantity of the sample. The fluorescence polarization immunodetection of environmental estrogen residues can be simply, quickly and high-throughout detected, and the sensitivity and the specificity are relatively high.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of fluorescence polarization immunoassay, and in particular to a method for detecting environmental estrogens based on fluorescence polarization immunoassay technology. Background Art

[0002] Environmental pollutants seriously endanger the health of marine ecology. In the seawater quality standards, more than 90% of new pollutants have no control standards, which is a blind spot for risk prevention and control. Endocrine disrupting chemicals (EDCs) are listed as new pollutants of high concern by the Ministry of Ecology and Environment. They are large in quantity and wide in scope, and the risks are prominent. As a typical endocrine disruptor, environmental estrogens (EEs) have system complexity and structural diversity, which makes some traditional instrumental analysis techniques, such as high-performance liquid chromatography and gas chromatography-mass spectrometry, unable to predict and screen a wide range of EEs, especially unidentified EEs. Therefore, identifying and quantifying potential EEs in the environment is crucial for environmental monitoring and risk assessment, and can promote continuous and in-depth improvement of the marine environment.

[0003] There are still many difficulties in the study of estrogens in the marine environment, such as trace concentrations and complex marine matrices. In addition, most existing analytical methods are limited to a certain category of EEs, and there is a lack of integrated analytical methods for simultaneously monitoring multiple categories of marine EEs. Therefore, it is of great significance to find technical methods that combine effect-oriented analysis with non-targeted screening to achieve simultaneous monitoring of a wide range of estrogenic substances in the ocean. Ligand-receptor interaction is the first step in the initiation process of nuclear receptor molecules, and the interaction between ligands and receptors is the most important factor in evaluating EDCs. Summary of the invention

[0004] The present invention provides a method for detecting environmental estrogens based on fluorescence polarization immunoassay technology, aiming to solve the problems of low detection efficiency, low sensitivity and low specificity of existing detection methods.

[0005] The embodiment of the present invention provides a method for detecting environmental estrogens based on fluorescence polarization immunoassay technology, the method comprising the steps of:

[0006] S1, using FITC as the fluorescent group and E2 derivative as the recognition group, the fluorescent probe F-E2 was designed and synthesized;

[0007] S2, obtaining the concentration of the fluorescent probe F-E2;

[0008] S3, obtaining the concentration of human estrogen receptor ERα-LBD;

[0009] S4, incubating the reaction mixture of the fluorescent probe F-E2 and the receptor ERα-LBD at room temperature and obtaining an optimal incubation time;

[0010] S5, adding 17β-estradiol to the reaction mixture, performing a competitive binding experiment, and measuring the corresponding mP value after incubation at room temperature;

[0011] S6. Draw the corresponding 17β-estradiol standard inhibition curve according to the mP value;

[0012] S7. Performing testing on the actual sample according to the method of step S5, comparing the measured polarized light intensity value with the standard inhibition curve of 17β-estradiol, and determining the estrogen residue in the sample.

[0013] Preferably, step S1 specifically includes the following steps:

[0014] S11, introducing an amino group through E2 to obtain an E2 derivative;

[0015] S12, coupling the E2 derivative with FITC to synthesize the fluorescent probe F-E2.

[0016] Preferably, the step S11 specifically includes the following steps:

[0017] NaN3 is added to the H2O solution of 3-chloropropylamine hydrochloride, and the reaction is heated to reflux. After the reaction is completed, KOH is added to the mixture after cooling to room temperature, and then extracted three times with an organic solvent, dried, and concentrated in vacuo to obtain a suspension a;

[0018] Ethinyl estradiol, tert-butyl alcohol and distilled water were added to the suspension a, and then ascorbic acid and CuSO4·5H2O were added, and the mixture was stirred at room temperature and monitored by TLC. The crude mixture was diluted with ethyl acetate and 4:1 saturated NH4Cl / NH4OH, and the organic layer was separated, dried and concentrated in vacuo to obtain a white solid b, i.e., the E2 derivative.

[0019] Preferably, the step S12 is specifically as follows: under an argon atmosphere, FITC and an E2 derivative are added to a flask respectively; then Et3N is added at room temperature or in 2 mL of anhydrous DMF, and then FITC and DIPEA are added, stirred at 80°C overnight and monitored by TLC; when the reaction is completed, purification is performed by column chromatography to obtain a yellow solid, namely, the fluorescent probe F-E2.

[0020] Preferably, the step S2 specifically includes the following steps:

[0021] Different concentrations of fluorescent probe F-E2 were diluted with 0.1M phosphate buffer (PBS, pH 7.4) containing 100μg / mL bovine γ-globulin, and the fluorescence was detected with a microplate reader. The polarized light intensity was 10 times that of the blank solution as the working concentration. At the same time, the stability of the mP value and the importance of low background should be taken into consideration, and 30nM F-E2 was determined as the optimal working concentration for the FP screening test.

[0022] Preferably, the step S3 specifically includes the following steps:

[0023] A total volume of 50 μL of reaction mixture containing 30 nM F-E2 and ERα-LBD in a 384-well black board was incubated at room temperature and the mP value was measured; the optimal ERα-LBD concentration was selected as the minimum amount to reach the saturated binding platform; among them, 800 nM was finally determined to be selected as the working concentration.

[0024] Preferably, the step S4 specifically includes the following steps:

[0025] The reaction mixture containing 30 nM F-E2 and ERα-LBD was incubated at room temperature for 1 to 10 hours, and the mP value was recorded separately using an ELISA reader; the optimal incubation time was finally determined to be 3 h.

[0026] Preferably, the step S5 specifically includes the following steps:

[0027] E2 concentration: diluted with 1% DMSO to 2.95E-10 ~ 5.90E-04nM;

[0028] Optimal volume of E2 added: Add different volumes of 1% DMSO to the reaction mixture of F-E2 and ERα-LBD, and measure the mP value after incubation at room temperature;

[0029] Different concentrations of 17β-estradiol were added to the reaction mixture containing 30 nM F-E2 and 800 nM ERα-LBD, and the mP values ​​were measured after incubation at room temperature.

[0030] Preferably, the step S6 specifically includes the following steps:

[0031] The standard inhibition logarithmic curve of E2 was established by plotting the inhibition rate mP / mP0 as the ordinate and the logarithmic value of the concentration of E2 as the abscissa.

[0032] Compared with the prior art, the beneficial effect of the present invention is that, through the above-mentioned steps S1-S7, through the effect-oriented analysis combined with the research method of non-targeted screening, a rapid and efficient detection method is provided for realizing the simultaneous monitoring of a wide range of estrogen substances in the actual water environment. The present invention is simple to operate and has a fast detection speed. The concentration of the analyte is determined by measuring the change in fluorescence polarization. Combined with the estrogen receptor competitive screening method, the results can be obtained immediately. It is suitable for high-throughput sample monitoring, which is helpful for large-scale sample detection and accelerating scientific research needs. The high specificity and high affinity of the immune response make fluorescence polarization immunoassay extremely selective and sensitive. The method is simple to operate, high-throughput, and reliable in results. The detection limit is 8.065nM, the linear range is 25.218~663.035nM, and R 2 is 0.9991. BRIEF DESCRIPTION OF THE DRAWINGS

[0033] The present invention will be described in detail below in conjunction with the accompanying drawings. The above and other aspects of the present invention will become clearer and easier to understand through the detailed description made in conjunction with the following drawings. In the accompanying drawings:

[0034] Figure 1 It is a flow chart of a method for detecting environmental estrogens based on fluorescence polarization immunoassay technology provided by an embodiment of the present invention;

[0035] Figure 2 It is the standard inhibition logarithmic curve of 17β-estradiol provided in the examples of the present invention. DETAILED DESCRIPTION

[0036] In order to make the purpose, technical solution and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not intended to limit the present invention.

[0037] Combined with Figure 1-Figure 2 As shown, the embodiment of the present invention provides a method for detecting environmental estrogens based on fluorescence polarization immunoassay technology, and the method comprises the steps of:

[0038] S1. Using FITC as the fluorescent group and E2 derivatives as the recognition group, the fluorescent probe F-E2 was designed and synthesized. Among them, using FITC as the fluorescent group and E2 derivatives as the recognition group, the fluorescent probe F-E2 was designed and synthesized; and 17β-estradiol standard was used as a competitor to compete with F-E2 for binding to human estrogen receptors, and a fluorescence polarization immunoassay method for environmental estrogens was established.

[0039] S2. Obtain the concentration of the fluorescent probe F-E2.

[0040] S3. Obtain the concentration of human estrogen receptor ERα-LBD.

[0041] S4. Incubate the reaction mixture of the fluorescent probe F-E2 and the receptor ERα-LBD at room temperature and obtain the optimal incubation time.

[0042] S5. Add 17β-estradiol to the reaction mixture to perform a competitive binding experiment. After incubation at room temperature, measure the corresponding mP value.

[0043] S6. Draw the corresponding 17β-estradiol standard inhibition curve based on the mP value.

[0044] S7. Performing testing on the actual sample according to the method of step S5, comparing the measured polarized light intensity value with the standard inhibition curve of 17β-estradiol, and determining the estrogen residue in the sample.

[0045] Specifically, through the above-mentioned steps S1-S7, through the effect-oriented analysis combined with the research method of non-targeted screening, a rapid and efficient detection method is provided for realizing the simultaneous monitoring of a wide range of estrogen substances in the actual water environment. The present invention is simple to operate and has a fast detection speed. The concentration of the analyte is determined by measuring the change in fluorescence polarization. Combined with the estrogen receptor competitive screening method, the results can be obtained immediately. It is suitable for high-throughput sample monitoring, which is helpful for large-scale sample detection and accelerating scientific research needs. The high specificity and high affinity of the immune response make fluorescence polarization immunoassay extremely selective and sensitive. This method is simple to operate, high-throughput, and reliable in results. The detection limit is 8.065nM, the linear range is 25.218~663.035nM, and R 2 is 0.9991.

[0046] In this embodiment, step S1 specifically includes the following steps:

[0047] S11, introducing an amino group through E2 to obtain an E2 derivative;

[0048] S12, coupling the E2 derivative with FITC to synthesize the fluorescent probe F-E2.

[0049] In this embodiment, the step S11 specifically includes the following steps:

[0050] NaN3 was added to the H2O solution of 3-chloropropylamine hydrochloride, and the reaction was heated to reflux. After the reaction was completed, KOH was added to the mixture after cooling to room temperature, and then extracted three times with an organic solvent, dried, and concentrated in vacuo to obtain a suspension a.

[0051] Specifically, NaN3 (0.75 g) was added to a solution of 3-chloropropylamine hydrochloride (0.5 g) in H2O (2 mL), and the reaction was heated to 80°C for 15 h. After the reaction was completed, KOH was added to the mixture after cooling to room temperature, and then extracted three times with dichloromethane, and the organic matter was combined and dried with Na2SO4 to obtain a suspension a.

[0052] Ethinyl estradiol, tert-butyl alcohol and distilled water were added to the suspension a, and then ascorbic acid and CuSO4·5H2O were added, and the mixture was stirred at room temperature and monitored by TLC. The crude mixture was diluted with ethyl acetate and 4:1 saturated NH4Cl / NH4OH, and the organic layer was separated, dried and concentrated in vacuo to obtain a white solid b, i.e., the E2 derivative.

[0053] Specifically, add ethinyl estradiol (300 mg, 1 mmol), tert-butyl alcohol (5 mL), distilled water (5 mL), ascorbic acid (20 mg, 0.11 mmol) and CuSO4·5H2O (30 mg, 0.12 mmol) to the suspension a, and stir at 25°C for 12 h. The crude mixture is diluted with ethyl acetate (40 mL) and 4:1 saturated NH4Cl / NH4OH (40 mL). The organic layer is separated, washed with 4:1 saturated NH4Cl / NH4OH (3×40 mL), dried, and concentrated in vacuo to obtain a white solid b, i.e., the E2 derivative.

[0054] In this embodiment, step S12 is specifically as follows: under an argon atmosphere, FITC and an E2 derivative are added to a flask respectively; then Et3N is added at room temperature or in 2 mL of anhydrous DMF, and then FITC and DIPEA are added, stirred at 80°C overnight and monitored by TLC; when the reaction is completed, purification is performed by column chromatography to obtain a yellow solid, namely, the fluorescent probe F-E2.

[0055] Specifically, under an argon atmosphere, FITC (1 mmol) and E2 derivatives were added to a flask, respectively. Then Et3N (5 mL) was added at room temperature or with 2 mL of anhydrous DMF, followed by FITC (1 mmol) and DIPEA, stirred overnight at 80 ° C and monitored by TLC. When the reaction was complete, it was purified by column chromatography (methanol / dichloromethane) to obtain a yellow solid (0.5, 63%), i.e., fluorescent probe F-E2. The probe was stored in the dark at 4 ° C until use.

[0056] In this embodiment, step S2 specifically includes the following steps:

[0057] Different concentrations of fluorescent probe F-E2 were diluted with 0.1M phosphate buffer (PBS, pH 7.4) containing 100μg / mL bovine γ-globulin, and the fluorescence was detected with a microplate reader. The polarized light intensity was 10 times that of the blank solution as the working concentration. At the same time, the stability of the mP value and the importance of low background should be taken into consideration, and 30nM F-E2 was determined as the optimal working concentration for the FP screening test.

[0058] Specifically, different concentrations of fluorescent probe F-E2 were diluted with 0.1M phosphate buffer (PBS, pH 7.4) containing 100μg / mL bovine gamma globulin (BGG), and fluorescence was detected by a microplate reader. The polarized light intensity of 10 times that of the blank solution was used as the working concentration. Considering the stability of the mP value and the importance of low background, 30nM F-E2 was determined as the optimal working concentration for the FP screening test.

[0059] In this embodiment, step S3 specifically includes the following steps:

[0060] A total volume of 50 μL of reaction mixture containing 30 nM F-E2 and ERα-LBD in a 384-well black board was incubated at room temperature and the mP value was measured; the optimal ERα-LBD concentration was selected as the minimum amount to reach the saturated binding platform; among them, 800 nM was finally determined to be selected as the working concentration.

[0061] Specifically, a total volume of 50 μL of a reaction mixture containing 30 nM F-E2 and ERα-LBD (0-3200 nM) was incubated at room temperature in a 384-well black plate and the mP value was measured. The optimal ERα-LBD concentration should be the minimum amount that reaches the saturated binding platform, and finally 800 nM was determined as the working concentration.

[0062] In this embodiment, step S4 specifically includes the following steps:

[0063] The reaction mixture containing 30 nM F-E2 and ERα-LBD (800 nM) was incubated at room temperature for 1 to 10 hours, and the mP value was recorded separately using an ELISA reader; the optimal incubation time was finally determined to be 3 h.

[0064] In this embodiment, step S5 specifically includes the following steps:

[0065] E2 concentration: diluted with 1% DMSO to 2.95E-10 ~ 5.90E-04nM;

[0066] Optimal volume of E2 added: Add different volumes of 1% DMSO to the reaction mixture of F-E2 and ERα-LBD, and measure the mP value after incubation at room temperature;

[0067] Different concentrations of 17β-estradiol (a potent natural estrogen, E2) were added to the reaction mixture containing 30 nM F-E2 and 800 nM ERα-LBD, and the mP values ​​were measured after incubation at room temperature.

[0068] Specifically, 17β-estradiol (a potent natural estrogen, E2) was added to conduct a competitive binding experiment, and the steps are as follows:

[0069] Concentration of E2: diluted with 1% DMSO to 2.95E-10 to 5.90E-04 nM.

[0070] Optimal volume of E2 added: Add different volumes of 1% DMSO (0-10uL) to the reaction mixture of F-E2 and ERα-LBD, and measure the mP value after incubation at room temperature. To ensure competitive binding, the optimal volume of E2 added was finally selected as 5μL.

[0071] Different concentrations of 17β-estradiol were added to the reaction mixture containing 30 nM F-E2 and 800 nM ERα-LBD, and the mP values ​​were measured after incubation at room temperature.

[0072] In this embodiment, step S6 specifically includes the following steps:

[0073] The standard inhibition logarithmic curve of E2 was established by plotting the inhibition rate mP / mP0 as the ordinate and the logarithmic value of the concentration of E2 as the abscissa.

[0074] In this embodiment, Figure 2 is the standard inhibition logarithmic curve of 17β-estradiol of the present invention;

[0075] The test results are as follows:

[0076] 1. Standard curve: The linear range of the environmental estrogen detection obtained by the present invention is 25.218-663.035 nM.

[0077] 2. Sensitivity: Sensitivity is the concentration of the standard corresponding to the 90% maximum polarized light value, i.e. IC 10 It is 8.065nM.

[0078] It should be noted that, in this article, the terms "include", "comprises" or any other variations thereof are intended to cover non-exclusive inclusion, so that a process, article or device including a series of elements includes not only those elements, but also other elements not explicitly listed, or also includes elements inherent to such process, article or device. In the absence of more restrictions, an element defined by the sentence "includes a ..." does not exclude the existence of other identical elements in the process, article or device including the element.

[0079] The embodiments of the present invention are described above in conjunction with the accompanying drawings. What is disclosed is only the preferred embodiment of the present invention. However, the present invention is not limited to the above-mentioned specific implementation manner. The above-mentioned specific implementation manner is only illustrative rather than restrictive. Under the enlightenment of the present invention, ordinary technicians in this field can also make many forms and equivalent changes without departing from the scope of protection of the purpose of the present invention and the claims, all of which are within the protection of the present invention.

Claims

1. A method for detecting environmental estrogens based on fluorescence polarization immunoassay technology. It is characterized in that The method comprises the steps of: S1, using FITC as the fluorescent group, E 2 The derivative is used as the recognition group, and the fluorescent probe FE is designed and synthesized. 2 ; S2. Obtain the fluorescent probe FE 2 concentration; S3, obtaining the concentration of human estrogen receptor ERα-LBD; S4, the fluorescent probe FE 2 The reaction mixture with the receptor ERα-LBD was incubated at room temperature and the optimal incubation time was obtained; S5, adding 17β-estradiol to the reaction mixture, performing a competitive binding experiment, and measuring the corresponding mP value after incubation at room temperature; S6. Draw the corresponding 17β-estradiol standard inhibition curve according to the mP value; S7. Performing testing on the actual sample according to the method of step S5, comparing the measured polarized light intensity value with the standard inhibition curve of 17β-estradiol, and determining the estrogen residue in the sample.

2. The method for detecting environmental estrogens based on fluorescence polarization immunoassay technology according to claim 1, It is characterized in that Step S1 specifically includes the following steps: S11, through E 2 Introduce amino group to obtain E 2 derivative; S12, the E 2 The derivative was coupled with FITC to synthesize the fluorescent probe FE 2 .

3. The method for detecting environmental estrogens based on fluorescence polarization immunoassay technology as claimed in claim 2, It is characterized in that The step S11 specifically includes the following steps: To 3-chloropropylamine hydrochloride 2 Add NaN to the O solution 3 , and the reaction was heated to reflux. After the reaction was completed, the mixture was cooled to room temperature, KOH was added to the mixture, and then extracted three times with an organic solvent, dried, and concentrated in vacuo to obtain a suspension a; Add ethinyl estradiol, tert-butyl alcohol and distilled water to the suspension a, and then add ascorbic acid and CuSO 4 ·5H 2 O, stirred at room temperature and monitored by TLC, the crude mixture was washed with ethyl acetate and 4:1 saturated NH 4 Cl / NH 4 OH, the organic layer was separated, dried and concentrated in vacuo to obtain a white solid b, namely E 2 derivative.

4. The method for detecting environmental estrogens based on fluorescence polarization immunoassay technology as claimed in claim 3, It is characterized in that The step S12 is specifically as follows: in an argon atmosphere, FITC and E 2 The derivatives were added to the flask separately; then Et 3 N at room temperature or in 2 mL of anhydrous DMF, then FITC and DIPEA were added and stirred at 80 °C overnight and monitored by TLC; when the reaction was complete, it was purified by column chromatography to obtain a yellow solid, i.e., the fluorescent probe FE 2 .

5. The method for detecting environmental estrogens based on fluorescence polarization immunoassay technology according to claim 1, It is characterized in that The step S2 specifically includes the following steps: Different concentrations of fluorescent probe FE were diluted in 0.1 M phosphate buffer (PBS, pH 7.4) containing 100 μg / mL bovine γ-globulin. 2 , fluorescence was detected by an enzyme-labeled instrument; the polarized light intensity was 10 times that of the blank solution as the working concentration, and the stability of the mP value and the importance of low background were taken into consideration to determine the 30nM FE 2 As the optimal working concentration for FP screening assay.

6. The method for detecting environmental estrogens based on fluorescence polarization immunoassay technology according to claim 1, It is characterized in that The step S3 specifically comprises the following steps: A total volume of 50 μL containing 30 nM FE was added to a 384-well black plate. 2 The reaction mixture with ERα-LBD was incubated at room temperature and the mP value was measured; the optimal ERα-LBD concentration was selected as the minimum amount to reach the saturated binding platform; finally, 800 nM was determined to be selected as the working concentration.

7. The method for detecting environmental estrogens based on fluorescence polarization immunoassay technology according to claim 6, It is characterized in that The step S4 specifically comprises the following steps: The 30 nM FE 2 The reaction mixture with ERα-LBD was incubated at room temperature for 1 to 10 hours, and the mP value was recorded separately using an ELISA reader; the optimal incubation time was finally determined to be 3 hours.

8. The method for detecting environmental estrogens based on fluorescence polarization immunoassay technology according to claim 1, It is characterized in that The step S5 specifically comprises the following steps: E 2 Concentration: diluted with 1% DMSO to 2.95E-10~5.90E-04nM; E 2 Optimal addition volume: Add different volumes of 1% DMSO to FE 2 In the reaction mixture with ERα-LBD, the mP value was measured after incubation at room temperature; Contains 30nM FE 2 Different concentrations of 17β-estradiol were added to the reaction mixture containing 100 nM ERα-LBD and 800 nM ERα-LBD. After incubation at room temperature, the mP values ​​were measured.

9. The method for detecting environmental estrogens based on fluorescence polarization immunoassay technology according to claim 1, It is characterized in that The step S6 specifically comprises the following steps: Inhibition rate mP / mP 0 As the vertical axis, E 2 The logarithm of the concentration is taken as the horizontal axis, and the E 2 The standard inhibition logarithmic curve of

Citation Information

Patent Citations

  • Method for detecting exogenous endocrine disrupting chemical and detection apparatus

    WO2001027619A1